$ANTX 4/A SEC Filings

Filed On	Filing
29 Mar 2024	Form 4/A: Eckburg Paul, Chief Medical Officer Received 30,000 shares as a grant or award
29 Mar 2024	Form 4/A: Day Lucy, Chief Financial Officer Received 27,500 shares as a grant or award
29 Mar 2024	Form 4/A: Eizen Joshua M, Chief Legal Officer Received 30,000 shares as a grant or award
29 Mar 2024	Form 4/A: Krause Kevin Michael, Chief Strategy Officer Received 30,000 shares as a grant or award
29 Mar 2024	Form 4/A: Chanda Sanjay, Chief Development Officer Received 27,500 shares as a grant or award
29 Mar 2024	Form 4/A: Easom Eric, Director Received 99,000 shares as a grant or award
24 Jun 2022	Form 4/A: Adjuvant Global Health Technology Fund, L.p., 10% owner and 3 others Received 2,430,714 shares by conversion · Bought 166,666 shares ($2.5M)

Comments